Epidiolex

FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
Forbes
FDA
GW Pharma
Epidiolex
epilepsy
advisory panels
Flag link:
GW Pharma riding high as cannabinoid Epidiolex nears first U.S. approval
GW Pharma riding high as cannabinoid Epidiolex nears first U.S. approval
Fierce Biotech
GW Pharma
Epidiolex
FDA
epilepsy
Flag link:
3 Biotechs That Could Get Big Boosts in April
3 Biotechs That Could Get Big Boosts in April
Motley Fool
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
Flag link:
3 Blockbuster Drug Launches to Watch In 2018
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
Flag link:
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Flag link:
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Endpoints
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures
Flag link:
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
Flag link:
A Tiny Biotech Just Dealt a Big Blow to Marijuana's Use in Epilepsy
A Tiny Biotech Just Dealt a Big Blow to Marijuana's Use in Epilepsy
Motley Fool
biotech
marijuana
epilepsy
ZX008
Zogenix
Epidiolex
GW Pharma
seizures
Flag link:
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Motley Fool
Zogenix
GW Pharma
Sativex
Epidiolex
LGS
Dravet syndrome
Flag link:
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
Xtalks
GW Pharma
cannabis
clinical trials
Epidiolex
epilepsy
Dravet syndrome
Flag link:
3 Reasons GW Pharmaceuticals Stock Could Rise
3 Reasons GW Pharmaceuticals Stock Could Rise
Motley Fool
GW Pharma
Epidiolex
Flag link:
3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success
3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success
Endpoints
GW Pharma
FDA
Epidiolex
epilepsy
Flag link:
GW Pharma to raise $252 mln after cannabis drug success
GW Pharma to raise $252 mln after cannabis drug success
Yahoo/Reuters
GW Pharma
marijuana
Epidiolex
Flag link:
5 Major Clinical Trial Results Coming Up
5 Major Clinical Trial Results Coming Up
24/7 Wall St
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
Flag link:
8 Major Biopharma Events Coming Later in 2016 and in 2017
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
Flag link:
GW Pharmaceuticals' Marijuana-Based Drug Hits the Mark in Pivotal-Stage Study
GW Pharmaceuticals' Marijuana-Based Drug Hits the Mark in Pivotal-Stage Study
Motley Fool
GW Pharma
marijuana
epilepsy
anti-seizure
Epidiolex
Flag link:
GW Pharma CEO jumps to the U.S., betting on epilepsy approval
GW Pharma CEO jumps to the U.S., betting on epilepsy approval
Fierce Biotech
GW Pharma
epilepsy
cannabis
Justin Gover
Epidiolex
Flag link:
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
BioPharma Dive
GW Pharma
epilepsy
cannabis
Epidiolex
Flag link:
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
The Fly on the Wall
GW Pharma
epilpesy
marijuana
Epidiolex
Flag link:
GW Pharma Up On Positive Data For Epilepsy Drug
GW Pharma Up On Positive Data For Epilepsy Drug
Investors.com
epilepsy
GW Pharma
Epidiolex
Flag link:

Pages